Edition:
United States

Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

28.25USD
26 May 2017
Change (% chg)

$-0.45 (-1.57%)
Prev Close
$28.70
Open
$28.55
Day's High
$28.85
Day's Low
$28.10
Volume
107,794
Avg. Vol
305,396
52-wk High
$29.95
52-wk Low
$11.85

Latest Key Developments (Source: Significant Developments)

Accelerate Diagnostics prices upsized offering of 2.75 mln shares at $28.85 per share
Tuesday, 9 May 2017 10:00pm EDT 

May 9 (Reuters) - Accelerate Diagnostics Inc :Accelerate diagnostics announces pricing of upsized public offering of common stock.Public offering of 2.75 million shares of its common stock upsized from original share offering of 2.5 million shares.Accelerate diagnostics -offering upsized from original share offering of 2.5 million shares of common stock, at price to public of $28.85 per share.  Full Article

Accelerate Diagnostics announces proposed public offering of common stock
Monday, 8 May 2017 04:15pm EDT 

May 8 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics announces proposed public offering of common stock.Accelerate Diagnostics Inc says has commenced an underwritten public offering of 2.5 million shares of its common stock.  Full Article

Accelerate Diagnostics reports Q1 sales $530,000
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports 191 instruments under contract and 3x revenue growth for first quarter 2017.Q1 sales $530,000 versus $163,000.Q1 revenue view $1.2 million -- Thomson Reuters I/B/E/S.Q1 loss per share $0.27.Q1 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.  Full Article

Accelerate Diagnostics reports Q1 sales $530,000
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports 191 instruments under contract and 3X revenue growth for first quarter 2017.Q1 sales $530,000 versus $163,000.Q1 loss per share $0.27.Q1 revenue view $1.2 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.  Full Article

Accelerate diagnostics submits De Novo request to FDA for phenosystem and phenotest BC kit
Monday, 11 Jul 2016 05:00am EDT 

Accelerate Diagnostics : Accelerate diagnostics submits de novo request to fda for accelerate pheno(tm) system and accelerate phenotest(tm) bc kit .Submitted de novo request for evaluation of automatic class iii designation to u.s. Fda for pheno system and phenotest bc kit.  Full Article

Accelerate Diagnostics Inc announces proposed public offering of common stock
Tuesday, 8 Dec 2015 04:01pm EST 

Accelerate Diagnostics Inc:Has commenced an underwritten public offering of $80 million of shares of its common stock.  Full Article

More From Around the Web

BRIEF-Accelerate Diagnostics announces closing of $79.3 mln upsized offering

* Accelerate Diagnostics announces closing of $79.3 million upsized offering Source text for Eikon: Further company coverage: